Europe - Frankfurt Stock Exchange - FRA:QS51 - CH1175448666 - Common Stock
The current stock price of QS51.DE is 106.25 EUR. In the past month the price increased by 7.54%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.78 | 109.21B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 19.29 | 52.00B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.52 | 23.54B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.52 | 23.54B | ||
| BIM.PA | BIOMERIEUX | 29.74 | 13.59B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 147.87 | 4.45B | ||
| DIA.MI | DIASORIN SPA | 21.82 | 4.04B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 26.3 | 3.79B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 11.16 | 1.35B | ||
| ELN.MI | EL.EN. SPA | 22.44 | 1.15B | ||
| DRW8.DE | DRAEGERWERK AG | 8.99 | 1.09B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 24.18 | 998.53M |
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. The company is headquartered in Basel, Basel-Stadt and currently employs 11,948 full-time employees. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
STRAUMANN HOLDING AG-REG
Peter Merian-Weg 12
Basel BASEL-STADT CH
Employees: 11948
Phone: 41619651111
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. The company is headquartered in Basel, Basel-Stadt and currently employs 11,948 full-time employees. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
The current stock price of QS51.DE is 106.25 EUR. The price increased by 4.53% in the last trading session.
STRAUMANN HOLDING AG-REG (QS51.DE) has a dividend yield of 1.02%. The yearly dividend amount is currently 0.91.
QS51.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
STRAUMANN HOLDING AG-REG (QS51.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
The Revenue of STRAUMANN HOLDING AG-REG (QS51.DE) is expected to grow by 4.63% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
STRAUMANN HOLDING AG-REG (QS51.DE) has a market capitalization of 16.94B EUR. This makes QS51.DE a Large Cap stock.
ChartMill assigns a technical rating of 5 / 10 to QS51.DE.
ChartMill assigns a fundamental rating of 7 / 10 to QS51.DE. QS51.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months QS51.DE reported a non-GAAP Earnings per Share(EPS) of 2.83. The EPS decreased by -14.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.29% | ||
| ROA | 11.23% | ||
| ROE | 19.18% | ||
| Debt/Equity | 0.1 |
25 analysts have analysed QS51.DE and the average price target is 123.81 EUR. This implies a price increase of 16.53% is expected in the next year compared to the current price of 106.25.
For the next year, analysts expect an EPS growth of 13.87% and a revenue growth 4.63% for QS51.DE